2016 State of Drug Development:
From Molecule to Market
The BioPharma Dive inaugural survey “2016 State of Drug Development” is complete.
We surveyed more than 800 biopharma industry leaders to provide insight into the challenges for pharma and biotech companies in drug development. The resultant report explores key trends in the industry and is designed to illustrate the major challenges and opportunities in the biopharma space.
See what we learned, download the report!
A Catalent representative may contact you with additional information.